Europe Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024

List of Tables

The Europe Clinical Risk Grouping Solution Market would witness market growth of 12.7% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $111.2 million by 2031. The UK market is exhibiting a CAGR of 11.8% during (2024 - 2031). Additionally, The France market would experience a CAGR of 13.9% during (2024 - 2031).

The growing need for personalized medicine is having a big impact on the adoption of clinical risk grouping solutions. This is because healthcare practitioners are becoming more aware of the significance of tailoring treatment programs to meet the needs of individual patients to meet their specific needs.

Additionally, personalized medicine, or precision medicine, aims to customize healthcare based on a patient's genetic makeup, lifestyle, environment, and other personal factors. This approach contrasts with the traditional one-size-fits-all treatment model, which may not be effective for everyone. By focusing on the individual, personalized medicine seeks to enhance the effectiveness of care, reduce the incidence of adverse effects, and improve overall patient outcomes.

Europe's clinical risk grouping solution market is expanding steadily, driven by various factors, including the aging population, rising healthcare expenditures, and the need for more efficient healthcare management systems. In Germany, the aging population is a significant factor driving the demand for clinical risk grouping solutions. According to the Federal Statistical Office of Germany (Destatis), by the mid-2030s, the number of individuals in Germany who are at least 67 years of age will increase by approximately 4 million to a minimum of 20.0 million. The escalating prevalence of age-related chronic conditions, including cardiovascular diseases, diabetes, and dementia, necessitates the more efficient administration of healthcare resources as the population ages.

Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Conduent, Incorporated
3M Company
Oracle Corporation (Cerner Corporation)
Microsoft Corporation (Nuance Communications, Inc.)
Health Catalyst, Inc.
Koninklijke Philips N.V.
Siemens Healthineers AG (Siemens AG)
HBI Solutions
Lightbeam Health Solutions
Reveleer

Europe Clinical Risk Grouping Solution Market Report Segmentation

By Product

Software
Services

By End-use

Hospitals & Clinics
Ambulatory Surgical Centers
Long Term Care Centers
Other

By Deployment

Private Cloud
Public Cloud
Hybrid Cloud

By Application

Population Health Management
Chronic Disease Management
Clinical Decision Support
Fraud Detection and Prevention
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Clinical Risk Grouping Solution Market, by Product
- 1.4.2 Europe Clinical Risk Grouping Solution Market, by End-use
- 1.4.3 Europe Clinical Risk Grouping Solution Market, by Deployment
- 1.4.4 Europe Clinical Risk Grouping Solution Market, by Application
- 1.4.5 Europe Clinical Risk Grouping Solution Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities:
- 3.2.4 Market Challenges:

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar - 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Europe Clinical Risk Grouping Solution Market by Product

5.1 Europe Software Market by Country
5.2 Europe Services Market by Country

Chapter 6. Europe Clinical Risk Grouping Solution Market by End-use

6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Ambulatory Surgical Centers Market by Country
6.3 Europe Long Term Care Centers Market by Country
6.4 Europe Other Market by Country

Chapter 7. Europe Clinical Risk Grouping Solution Market by Deployment

7.1 Europe Private Cloud Market by Country
7.2 Europe Public Cloud Market by Country
7.3 Europe Hybrid Cloud Market by Country

Chapter 8. Europe Clinical Risk Grouping Solution Market by Application

8.1 Europe Population Health Management Market by Country
8.2 Europe Chronic Disease Management Market by Country
8.3 Europe Clinical Decision Support Market by Country
8.4 Europe Fraud Detection and Prevention Market by Country
8.5 Europe Others Market by Country

Chapter 9. Europe Clinical Risk Grouping Solution Market by Country

9.1 Germany Clinical Risk Grouping Solution Market
- 9.1.1 Germany Clinical Risk Grouping Solution Market by Product
- 9.1.2 Germany Clinical Risk Grouping Solution Market by End-use
- 9.1.3 Germany Clinical Risk Grouping Solution Market by Deployment
- 9.1.4 Germany Clinical Risk Grouping Solution Market by Application
9.2 UK Clinical Risk Grouping Solution Market
- 9.2.1 UK Clinical Risk Grouping Solution Market by Product
- 9.2.2 UK Clinical Risk Grouping Solution Market by End-use
- 9.2.3 UK Clinical Risk Grouping Solution Market by Deployment
- 9.2.4 UK Clinical Risk Grouping Solution Market by Application
9.3 France Clinical Risk Grouping Solution Market
- 9.3.1 France Clinical Risk Grouping Solution Market by Product
- 9.3.2 France Clinical Risk Grouping Solution Market by End-use
- 9.3.3 France Clinical Risk Grouping Solution Market by Deployment
- 9.3.4 France Clinical Risk Grouping Solution Market by Application
9.4 Russia Clinical Risk Grouping Solution Market
- 9.4.1 Russia Clinical Risk Grouping Solution Market by Product
- 9.4.2 Russia Clinical Risk Grouping Solution Market by End-use
- 9.4.3 Russia Clinical Risk Grouping Solution Market by Deployment
- 9.4.4 Russia Clinical Risk Grouping Solution Market by Application
9.5 Spain Clinical Risk Grouping Solution Market
- 9.5.1 Spain Clinical Risk Grouping Solution Market by Product
- 9.5.2 Spain Clinical Risk Grouping Solution Market by End-use
- 9.5.3 Spain Clinical Risk Grouping Solution Market by Deployment
- 9.5.4 Spain Clinical Risk Grouping Solution Market by Application
9.6 Italy Clinical Risk Grouping Solution Market
- 9.6.1 Italy Clinical Risk Grouping Solution Market by Product
- 9.6.2 Italy Clinical Risk Grouping Solution Market by End-use
- 9.6.3 Italy Clinical Risk Grouping Solution Market by Deployment
- 9.6.4 Italy Clinical Risk Grouping Solution Market by Application
9.7 Rest of Europe Clinical Risk Grouping Solution Market
- 9.7.1 Rest of Europe Clinical Risk Grouping Solution Market by Product
- 9.7.2 Rest of Europe Clinical Risk Grouping Solution Market by End-use
- 9.7.3 Rest of Europe Clinical Risk Grouping Solution Market by Deployment
- 9.7.4 Rest of Europe Clinical Risk Grouping Solution Market by Application

Chapter 10. Company Profiles

10.1 Conduent, Incorporated
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
10.2 3M Company
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
10.3 Oracle Corporation (Cerner Corporation)
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
10.4 Microsoft Corporation (Nuance Communications, Inc.)
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Product Launches and Product Expansions:
- 10.4.6 SWOT Analysis
10.5 Health Catalyst, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Product Launches and Product Expansions:
  - 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
10.6 Koninklijke Philips N.V.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.6.5 Recent strategies and developments:
  - 10.6.5.1 Product Launches and Product Expansions:
  - 10.6.5.2 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 SWOT Analysis
10.8 HBI Solutions
- 10.8.1 Company Overview
10.9 Lightbeam Health Solutions
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
  - 10.9.2.1 Partnerships, Collaborations, and Agreements:
  - 10.9.2.2 Acquisition and Mergers:
10.10. Reveleer
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
  - 10.10.2.1 Acquisition and Mergers:

LIST OF TABLES

TABLE 1 Europe Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 2 Europe Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Enterprise Key Management Market
TABLE 4 Product Launches And Product Expansions- Enterprise Key Management Market
TABLE 5 Acquisition and Mergers- Enterprise Key Management Market
TABLE 6 Europe Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 7 Europe Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 8 Europe Software Market by Country, 2020 - 2023, USD Million
TABLE 9 Europe Software Market by Country, 2024 - 2031, USD Million
TABLE 10 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 11 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 12 Europe Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 13 Europe Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 14 Europe Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 15 Europe Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 16 Europe Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
TABLE 17 Europe Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
TABLE 18 Europe Long Term Care Centers Market by Country, 2020 - 2023, USD Million
TABLE 19 Europe Long Term Care Centers Market by Country, 2024 - 2031, USD Million
TABLE 20 Europe Other Market by Country, 2020 - 2023, USD Million
TABLE 21 Europe Other Market by Country, 2024 - 2031, USD Million
TABLE 22 Europe Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 23 Europe Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 24 Europe Private Cloud Market by Country, 2020 - 2023, USD Million
TABLE 25 Europe Private Cloud Market by Country, 2024 - 2031, USD Million
TABLE 26 Europe Public Cloud Market by Country, 2020 - 2023, USD Million
TABLE 27 Europe Public Cloud Market by Country, 2024 - 2031, USD Million
TABLE 28 Europe Hybrid Cloud Market by Country, 2020 - 2023, USD Million
TABLE 29 Europe Hybrid Cloud Market by Country, 2024 - 2031, USD Million
TABLE 30 Europe Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 31 Europe Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 32 Europe Population Health Management Market by Country, 2020 - 2023, USD Million
TABLE 33 Europe Population Health Management Market by Country, 2024 - 2031, USD Million
TABLE 34 Europe Chronic Disease Management Market by Country, 2020 - 2023, USD Million
TABLE 35 Europe Chronic Disease Management Market by Country, 2024 - 2031, USD Million
TABLE 36 Europe Clinical Decision Support Market by Country, 2020 - 2023, USD Million
TABLE 37 Europe Clinical Decision Support Market by Country, 2024 - 2031, USD Million
TABLE 38 Europe Fraud Detection and Prevention Market by Country, 2020 - 2023, USD Million
TABLE 39 Europe Fraud Detection and Prevention Market by Country, 2024 - 2031, USD Million
TABLE 40 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 41 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 42 Europe Clinical Risk Grouping Solution Market by Country, 2020 - 2023, USD Million
TABLE 43 Europe Clinical Risk Grouping Solution Market by Country, 2024 - 2031, USD Million
TABLE 44 Germany Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 45 Germany Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 46 Germany Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 47 Germany Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 48 Germany Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 49 Germany Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 50 Germany Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 51 Germany Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 52 Germany Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 53 Germany Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 54 UK Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 55 UK Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 56 UK Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 57 UK Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 58 UK Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 59 UK Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 60 UK Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 61 UK Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 62 UK Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 63 UK Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 64 France Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 65 France Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 66 France Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 67 France Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 68 France Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 69 France Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 70 France Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 71 France Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 72 France Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 73 France Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 74 Russia Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 75 Russia Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 76 Russia Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 77 Russia Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 78 Russia Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 79 Russia Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 80 Russia Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 81 Russia Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 82 Russia Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 83 Russia Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 84 Spain Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 85 Spain Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 86 Spain Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 87 Spain Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 88 Spain Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 89 Spain Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 90 Spain Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 91 Spain Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 92 Spain Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 93 Spain Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 94 Italy Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 95 Italy Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 96 Italy Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 97 Italy Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 98 Italy Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 99 Italy Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 100 Italy Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 101 Italy Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 102 Italy Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 103 Italy Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 104 Rest of Europe Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 105 Rest of Europe Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 106 Rest of Europe Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 107 Rest of Europe Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 108 Rest of Europe Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 109 Rest of Europe Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 110 Rest of Europe Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 111 Rest of Europe Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 112 Rest of Europe Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 113 Rest of Europe Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 114 Key Information -Conduent, Incorporated
TABLE 115 Key Information - 3M Company
TABLE 116 Key Information - Oracle Corporation
TABLE 117 Key Information - Microsoft Corporation
TABLE 118 Key Information - Health Catalyst, Inc.
TABLE 119 Key Information - Koninklijke Philips N.V.
TABLE 120 Key Information - Siemens Healthineers AG
TABLE 121 Key Information - HBI Solutions
TABLE 122 Key Information - Lightbeam Health Solutions
TABLE 123 Key Information - Reveleer

Europe Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents